{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:54:17Z","timestamp":1771469657304,"version":"3.50.1"},"reference-count":53,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["842001005"],"award-info":[{"award-number":["842001005"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Routine and international comparison of clinical outcomes enabling identification of best practices for patients with pulmonary sarcoidosis is lacking. The aim of this study was to develop a standard set of outcome measures for pulmonary sarcoidosis, using the value-based healthcare principles.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Six expert clinics for interstitial lung diseases in four countries participated in a consensus-driven RAND-modified Delphi study. A mixed-method approach was applied for the identification of an outcome measures set and initial conditions for patients with pulmonary sarcoidosis. The expert team consisted of multidisciplinary professionals (n=14) from Cleveland Clinic, Cincinnati MC, Erasmus MC, Leuven UZ, Royal Brompton and St. Antonius Hospital. During a ranking process, participants were instructed to rank variables on a scale from 1 to 10 based on whether it has (1) impact of the outcome on quality of life, (2) impact of quality of care on the outcome and (3) the number of patients negatively affected by the outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>An outcome measures set was defined consisting of seven outcome measures: mortality, pulmonary function, soluble interleukin-2 receptor change as an activity biomarker, weight gain, quality of life, osteoporosis and clinical outcome status.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Collecting outcomes in pulmonary sarcoidosis internationally and the use of a broadly accepted set can enable international comparison. Differences in outcomes can potentially be used as a starting point for quality improvement initiatives.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2018-000394","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:45:14Z","timestamp":1550555114000},"page":"e000394","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-3291","authenticated-orcid":false,"given":"Nynke A","family":"Kampstra","sequence":"first","affiliation":[{"name":"Department of Value-Based Healthcare, St. Antonius Hospital, Nieuwegein, The Netherlands"},{"name":"Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C","family":"Grutters","sequence":"additional","affiliation":[{"name":"Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands"},{"name":"Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frouke T","family":"van Beek","sequence":"additional","affiliation":[{"name":"Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A","family":"Culver","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P","family":"Baughman","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta A","family":"Renzoni","sequence":"additional","affiliation":[{"name":"Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Wuyts","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Universitaire Ziekenhuizen Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaslis","family":"Kouranos","sequence":"additional","affiliation":[{"name":"Department of Interstitial Lung Disease, Imperial College London\u2014Royal Brompton Campus, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies S","family":"Wijsenbeek","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douwe H","family":"Biesma","sequence":"additional","affiliation":[{"name":"Department of Value-Based Healthcare, St. Antonius Hospital, Nieuwegein, The Netherlands"},{"name":"Department of Internal Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J","family":"van der Wees","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul B","family":"van der Nat","sequence":"additional","affiliation":[{"name":"Department of Value-Based Healthcare, St. Antonius Hospital, Nieuwegein, The Netherlands"},{"name":"Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ Healthcare), Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"2025083109321213000_6.1.e000394.1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccm.2015.08.015","article-title":"Treatment of sarcoidosis","volume":"36","author":"Wijsenbeek","year":"2015","journal-title":"Clin Chest Med"},{"key":"2025083109321213000_6.1.e000394.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.10"},{"key":"2025083109321213000_6.1.e000394.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60680-7"},{"key":"2025083109321213000_6.1.e000394.4","unstructured":"Gerteis J , Izrael D , Deitz D , et al . Multiple chronic conditions chartbook. Rockville MD: Agency for Healthcare Research and Quality, 2014."},{"key":"2025083109321213000_6.1.e000394.5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00408-017-0076-4","article-title":"The burden of comorbidity and complexity in sarcoidosis: impact of associated chronic diseases","volume":"196","author":"Brito-Zer\u00f3n","year":"2018","journal-title":"Lung"},{"key":"2025083109321213000_6.1.e000394.6","first-page":"1261","article-title":"High-cost sarcoidosis patients in the United States: patient characteristics and patterns of health care resource utilization","volume":"23","author":"Rice","year":"2017","journal-title":"J Manag Care Spec Pharm"},{"key":"2025083109321213000_6.1.e000394.7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMp1511701","article-title":"Standardizing patient outcomes measurement","volume":"374","author":"Porter","year":"2016","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025083109321213000_6.1.e000394.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1011024"},{"key":"2025083109321213000_6.1.e000394.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"key":"2025083109321213000_6.1.e000394.10","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/j.lpm.2012.03.019","article-title":"Pulmonary manifestations of sarcoidosis","volume":"41","author":"Baughman","year":"2012","journal-title":"La Presse M\u00e9dicale"},{"key":"2025083109321213000_6.1.e000394.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00002512"},{"key":"2025083109321213000_6.1.e000394.12","first-page":"113","article-title":"Pulmonary sarcoidosis in the Nordic countries 1950\u20131982. II. Course and prognosis","volume":"7","author":"Milman","year":"1990","journal-title":"Sarcoidosis"},{"key":"2025083109321213000_6.1.e000394.13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1238913"},{"key":"2025083109321213000_6.1.e000394.14","doi-asserted-by":"crossref","unstructured":"McNamara RL , Spatz ES , Kelley TA , et al . Standardized outcome measurement for patients with coronary artery disease: consensus from the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc 2015;4. doi:doi:10.1161\/JAHA.115.001767","DOI":"10.1161\/JAHA.115.001767"},{"key":"2025083109321213000_6.1.e000394.15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.eururo.2015.06.007","article-title":"Development of a standardized set of patient-centered outcomes for advanced prostate cancer: an international effort for a unified approach","volume":"68","author":"Morgans","year":"2015","journal-title":"Eur Urol"},{"key":"2025083109321213000_6.1.e000394.16","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.11.2.110"},{"key":"2025083109321213000_6.1.e000394.17","unstructured":"Fitch K , Bernstein SJ , Aguilar MD , et al . The RAND\/UCLA appropriateness method user's manual. RAND, 2001."},{"key":"2025083109321213000_6.1.e000394.18","first-page":"90","article-title":"Endpoints for clinical trials of sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083109321213000_6.1.e000394.19","unstructured":"Kaplan RS , Porter ME . The big IDEA\u2014how to solve the cost crisis in health care. Harv Bus Rev 2012;46."},{"key":"2025083109321213000_6.1.e000394.20","unstructured":"Meetbaar Beter . Meetbaar Beter Boeken, 2013. Available: http:\/\/www.meetbaarbeter.com\/documents\/meetbaar-beter-boeken\/boeken-2013\/ [Accessed 11 Dec 2017]."},{"key":"2025083109321213000_6.1.e000394.21","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2018.02.037","article-title":"Defining and measuring a standard set of outcomes in coronary artery disease","volume":"121","author":"Daeter","year":"2018","journal-title":"Am J Cardiol"},{"key":"2025083109321213000_6.1.e000394.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201010-1679OC"},{"key":"2025083109321213000_6.1.e000394.23","first-page":"90","article-title":"Endpoints for clinical trials of sarcoidosis","volume":"29","author":"Baughman","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083109321213000_6.1.e000394.24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02591413","article-title":"The interleukin-2\/interleukin-2 receptor system: structural, immunological, and clinical features","volume":"22","author":"Semenzato","year":"1992","journal-title":"Int J Clin Lab Res"},{"key":"2025083109321213000_6.1.e000394.25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"2025083109321213000_6.1.e000394.26","doi-asserted-by":"publisher","DOI":"10.1373\/49.9.1510"},{"key":"2025083109321213000_6.1.e000394.27","first-page":"66","article-title":"Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET","volume":"55","author":"Keijsers","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2025083109321213000_6.1.e000394.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.2.406"},{"key":"2025083109321213000_6.1.e000394.29","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e32832d0403"},{"key":"2025083109321213000_6.1.e000394.30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir Med"},{"key":"2025083109321213000_6.1.e000394.31","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.rmed.2017.10.022","article-title":"No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis","volume":"138S","author":"Broos","year":"2018","journal-title":"Respir Med"},{"key":"2025083109321213000_6.1.e000394.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.12.009"},{"key":"2025083109321213000_6.1.e000394.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2008.03.012"},{"key":"2025083109321213000_6.1.e000394.34","doi-asserted-by":"crossref","unstructured":"Paramothayan NS , Lasserson TJ , Jones P , et al . Corticosteroids for pulmonary sarcoidosis. Cochrane Database Syst Rev 2005;5(5 Suppl).doi:10.1002\/14651858.CD001114.pub2","DOI":"10.1002\/14651858.CD001114.pub2"},{"key":"2025083109321213000_6.1.e000394.35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.4.989"},{"key":"2025083109321213000_6.1.e000394.36","first-page":"92","article-title":"Fatigue in sarcoidosis: American versus Dutch patients","volume":"26","author":"de Kleijn","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083109321213000_6.1.e000394.37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/1479972316661926","article-title":"Managing fatigue in sarcoidosis\u2014a systematic review of the evidence","volume":"14","author":"Atkins","year":"2017","journal-title":"Chron Respir Dis"},{"key":"2025083109321213000_6.1.e000394.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.05.004"},{"key":"2025083109321213000_6.1.e000394.39","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201962"},{"key":"2025083109321213000_6.1.e000394.40","first-page":"75","article-title":"Validation of the King's sarcoidosis questionnaire (KSQ) in a Dutch sarcoidosis population","volume":"33","author":"Van Manen","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083109321213000_6.1.e000394.41","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083109321213000_6.1.e000394.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5261.1165"},{"key":"2025083109321213000_6.1.e000394.43","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083109321213000_6.1.e000394.44","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"key":"2025083109321213000_6.1.e000394.45","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-742OC"},{"key":"2025083109321213000_6.1.e000394.46","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201503-172OT"},{"key":"2025083109321213000_6.1.e000394.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2005.00605.x"},{"key":"2025083109321213000_6.1.e000394.48","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)91730-2"},{"key":"2025083109321213000_6.1.e000394.49","doi-asserted-by":"publisher","DOI":"10.1177\/135581969900400401"},{"key":"2025083109321213000_6.1.e000394.50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.surg.2014.08.097","article-title":"Clinical registries and quality measurement in surgery: a systematic review","volume":"157","author":"Stey","year":"2015","journal-title":"Surgery"},{"key":"2025083109321213000_6.1.e000394.51","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00141-2018"},{"key":"2025083109321213000_6.1.e000394.52","first-page":"337","article-title":"Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation","volume":"9","author":"Czerwi\u0144ski","year":"2007","journal-title":"Ortop Traumatol Rehabil"},{"key":"2025083109321213000_6.1.e000394.53","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2018-000394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:32:21Z","timestamp":1756657941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2018-000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2,18]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1136\/bmjresp-2018-000394"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2018-000394","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}